Medenecka Beata, Jelińska Anna, Zajac Marianna, Bałdyka Magdalena, Juszkiewicz Krzysztof, Oszczapowicz Irena
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznań University of Medical Sciences, 6 Grunwaldzka St., 60-780 Poznań, Poland.
Acta Pol Pharm. 2009 Sep-Oct;66(5):563-9.
The influence of temperature and relative air humidity on the stability of cefaclor monohydrate in crystalline form and in its pharmaceutical preparations (oral suspension and slow release tablets) was investigated. The process of degradation was studied by using high-performance liquid chromatography with ultraviolet (UV) detection, as described in the monograph of cefaclor in European Pharmacopoeia. The degradation of cefaclor monohydrate in substance, in oral suspension and tablets at relative air humidity RH > 50% is a first-order autocatalytic reaction relative to substrate concentration, while at 0% RH the degradation of cefaclor in substance is a first-order reaction relative to substrate concentration. The kinetic and thermodynamic parameters of degradation were calculated.
研究了温度和相对空气湿度对结晶形式的头孢克洛一水合物及其药物制剂(口服混悬液和缓释片)稳定性的影响。采用欧洲药典中头孢克洛专论所述的带紫外(UV)检测的高效液相色谱法研究降解过程。相对于底物浓度,在相对空气湿度RH > 50%时,头孢克洛一水合物在原料药、口服混悬液和片剂中的降解是一级自催化反应,而在0% RH时,头孢克洛原料药的降解是相对于底物浓度的一级反应。计算了降解的动力学和热力学参数。